Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2015-12-16

Clinical Trial Update: Xenetix® 350: Comparative Assessment of Image Quality for Coronary CT Angiography [Phase 4]

View source ↗

Summary

Phase 4 study by Guerbet evaluating image quality of Xenetix 350 for coronary CT angiography; the trial completed with results posted December 16, 2015.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Xenetix 350

Snippet

Sponsor: Guerbet | Conditions: Coronary Artery Disease | Phase 4 | Status: COMPLETED | Results posted: 2015-12-16